Literature DB >> 21153318

Pathogenic role of IL-6 combined with TNF-α or IL-1 in the induction of acute phase proteins SAA and CRP in chronic inflammatory diseases.

Kazuyuki Yoshizaki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21153318     DOI： 10.1007/978-1-4419-6612-4_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

1.  Amyloid and inflammation.

Authors:  Peter D Gorevic
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-25       Impact factor: 11.205

2.  High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential.

Authors:  Lambert Busque; Maxine Sun; Manuel Buscarlet; Sami Ayachi; Yassamin Feroz Zada; Sylvie Provost; Vincent Bourgoin; Luigina Mollica; Marlies Meisel; Reinhard Hinterleitner; Bana Jabri; Marie-Pierre Dubé; Jean-Claude Tardif
Journal:  Blood Adv       Date:  2020-06-09

3.  Synergistic effect of interleukin-17 and tumour necrosis factor-α on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways.

Authors:  A Beringer; N Thiam; J Molle; B Bartosch; P Miossec
Journal:  Clin Exp Immunol       Date:  2018-05-31       Impact factor: 4.330

4.  Within-person reproducibility of proteoforms related to inflammation and renal dysfunction.

Authors:  Jie Gao; Adrian McCann; Johnny Laupsa-Borge; Ottar Nygård; Per Magne Ueland; Klaus Meyer
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

5.  Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas.

Authors:  Jin Ho Shin; Chong Jai Kim; Eun Jeong Jeon; Chang Ohk Sung; Hwa Jeong Shin; Jene Choi; Eunsil Yu
Journal:  J Pathol Transl Med       Date:  2015-03-12

6.  Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations.

Authors:  Mutsa T Madondo; Sandra Tuyaerts; Brit B Turnbull; Anke Vanderstraeten; Holbrook Kohrt; Balasubramanian Narasimhan; Frederic Amant; Michael Quinn; Magdalena Plebanski
Journal:  J Transl Med       Date:  2014-06-23       Impact factor: 5.531

Review 7.  Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?

Authors:  Anca Cardoneanu; Alexandra Maria Burlui; Luana Andreea Macovei; Ioana Bratoiu; Patricia Richter; Elena Rezus
Journal:  Biomedicines       Date:  2022-01-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.